|
|
Blood, 1 August 2007, Vol. 110, No. 3, pp. 792-793.
 Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Comment on Burman et al, page 1064
The lung's friend, the gut's foe
Gerhard Hildebrandt
UNIVERSITY OF REGENSBURG MEDICAL SCHOOL
In this issue of Blood, Burman and colleagues provide a detailed experimental study of the ambiguous role of IFN in GVHD target-organ pathophysiology.
The development of severe interstitial pneumonitis, characteristic of idiopathic pneumonia syndrome (IPS) as a form of acute graft-versus-host disease (aGVHD) of the lung after allogeneic stem cell transplantation (SCT), is the result of a cascade of events involving conditioning toxicity, chemokine and cytokine production by host and donor cells, the influx of alloreactive donor immune cells, and the damage of host tissue by both major histocompatibility complex (MHC)-dependent and -independent pathways.1–5 Although similar mechanisms are responsible for the development of aGVHD in other target organs, such as the gastrointestinal (GI) tract, skin, or liver, distribution patterns, kinetics, and severity can vary between lung and other organs both in patients and in experimental studies.
IFN, as one of the most prominent Th1 cytokines, has been postulated to be a key player in aGVHD; however, results have been contradictory.6,7 In this issue of Blood, Burman and colleagues report on a preventive role of IFN in the development of IPS in contrast to its detrimental effects on GI-tract GVHD. Using IFN-deficient and IFN receptor (IFNR)-deficient animals as donors or recipients in a well-established murine model to induce aGVHD and IPS, they showed that, in the absence of IFN production by donor cells, early mortality after allogeneic SCT was increased due to severe interstitial pneumonitis, whereas aGVHD injury to other target organs was unaltered or slightly reduced. The preventive effects of donor-cell-derived IFN signaling on IPS development required the expression of IFNR on lung parenchymal cells, as chimeric mice, in which only the nonhematopoietic-cell compartment expressed this receptor, were protected from IPS; in contrast, only those animals with restricted expression of IFNR to the hematopoietic-cell compartment developed full disease severity. IFN-dependent protection from IPS was not mediated through nitric oxide or indoleamine 2,3 dioxygenase pathways, but rather involved the suppression of adhesion molecules leading to decreased leukocyte adhesion and migration to the lung.
Interestingly, in the same sets of experiments, the authors demonstrated that IFN-IFNR ligand-receptor interactions augmented systemic inflammation and aGVHD of the GI tract. Homing in again on IFNR being expressed on the parenchymal, but not on the hematopoietic, cell as the critical site of action, these data emphasize the ambiguous role of IFN by inducing aGVHD in the gut but preventing it in the lung.
The present study marks a significant advance in understanding the role of IFN in SCT immunology, and provides exciting insights into the different regulation of aGVHD pathophysiology of the lung and the GI tract. Using similar models for experimental IPS, previous groups have shown that histopathologic changes of the lung after allogeneic SCT become evident around 2 weeks after transplantation and progressively develop over time.3 The study by Burman and colleagues leads one to speculate that these kinetics may, in part, be due to protective immunodominant effects of elevated IFN levels early after transplantation, which then vanish over time, being replaced by other deleterious key players including TNF . Despite the fact that strain- and model-specific issues cannot be excluded, the data by Burman and colleagues suggest the inhibitory effects of IFN signaling pathways as a promising target for preventing and potentially treating IPS.
Footnotes
Conflict-of-interest disclosure: The author declares no competing financial interests. 
REFERENCES
- Cooke KR, Kobzik L, Martin TR, et al. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation. I: the roles of minor H antigens and endotoxin. Blood 1996; 88:3230–3239.[Abstract/Free Full Text]
- Fukuda T, Hackman RC, Guthrie KA, et al. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 2003; 102:2777–2785.[Abstract/Free Full Text]
- Hildebrandt GC, Olkiewicz KM, Choi S, et al. Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation. Blood 2005; 105:2249–2257.
- Panoskaltsis-Mortari A, Strieter RM, Hermanson JR, et al. Induction of monocyte- and T-cell-attracting chemokines in the lung during the generation of idiopathic pneumonia syndrome following allogeneic murine bone marrow transplantation. Blood 2000; 96:834–839.[Abstract/Free Full Text]
- Shukla M, Yang S, Milla C, et al. Absence of host tumor necrosis factor receptor 1 attenuates manifestations of idiopathic pneumonia syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288:942–949.[CrossRef]
- Puliaev R, Nguyen P, Finkelman FD, Via CS. Differential requirement for IFN-gamma in CTL maturation in acute murine graft-versus-host disease. J Immunol 2004; 173:910–919.[Abstract/Free Full Text]
- Murphy WJ, Welniak LA, Taub DD, et al. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest 1998; 102:1742–1748.[Medline]
[Order article via Infotrieve]
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
Related Article in Blood Online:
-
IFN differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract
- Angela C. Burman, Tatjana Banovic, Rachel D. Kuns, Andrew D. Clouston, Amanda C. Stanley, Edward S. Morris, Vanessa Rowe, Helen Bofinger, Renae Skoczylas, Neil Raffelt, Olivier Fahy, Shaun R. McColl, Christian R. Engwerda, Kelli P. A. McDonald, and Geoffrey R. Hill
Blood 2007 110: 1064-1072.
[Abstract]
[Full Text]
[PDF]
|
|
